+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Glycerine Market by Utility, Source - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5716464
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pharmaceutical Glycerine Market grew from USD 37.47 million in 2023 to USD 39.40 million in 2024. It is expected to continue growing at a CAGR of 5.94%, reaching USD 56.13 million by 2030.

Pharmaceutical glycerine is a high-purity form of glycerine used in medicine, primarily as a solvent, humectant, and preservative in drug formulations. Its necessity arises from its role in ensuring stability and effectiveness in medicines by improving solubility and moisture retention. The application of pharmaceutical glycerine spans across tablets, syrups, ointments, and as a base in topical creams, making its end-use scope broad and critical in the pharmaceutical industry. The market's growth is influenced by increasing demand for pharmaceutical products, focus on innovative drug delivery systems, and growing awareness of the benefits of glycerine in medical formulations. Additionally, regulatory approvals promoting the use of biodegradable raw materials are further propelling this market. Potential opportunities lie in expanding pharmaceutical manufacturing sectors in emerging markets and advancements in doping glycerine for targeted drug delivery systems. Companies should invest in collaborative R&D initiatives to innovate and optimize the use of glycerine, potentially leading to cost reductions and higher efficacy products. However, market growth faces challenges from fluctuating raw material prices, strict regulatory scrutiny, and potential alternatives like polyethylene glycol. Regulatory variances across countries can also hinder seamless market expansion. Despite these obstacles, areas ripe for innovation include the exploration of glycerine derivatives and exploring its use in biologics manufacturing. Companies should focus strategic efforts on sustainable production processes and enhancing traceability to meet regulatory compliance and consumer preferences for transparency. The pharmaceutical glycerine market is of oligopolistic nature, characterized by a few dominant players who influence pricing and distribution networks. Businesses keen on entering or expanding in this market should prioritize strategic partnerships and adopt agile strategies to navigate technical and regulatory challenges, ensuring a competitive edge and market resilience.

Understanding Market Dynamics in the Pharmaceutical Glycerine Market

The Pharmaceutical Glycerine Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing usage as excipients in pharmaceutical preparations
    • Rising adoption of natural ingredients
    • Increasing application in the treatment of eye pressure conditions
  • Market Restraints
    • Adverse effects of pharmaceutical glycerine
  • Market Opportunities
    • Rising R&D activities to develop pharmaceutical glycerine
    • Improvements in supply chain and distribution network
  • Market Challenges
    • Availability of low cost substitutes

Exploring Porter’s Five Forces for the Pharmaceutical Glycerine Market

Porter’s Five Forces framework further strengthens the insights of the Pharmaceutical Glycerine Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pharmaceutical Glycerine Market

External macro-environmental factors deeply influence the performance of the Pharmaceutical Glycerine Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pharmaceutical Glycerine Market

The Pharmaceutical Glycerine Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pharmaceutical Glycerine Market

The Pharmaceutical Glycerine Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Pharmaceutical Glycerine Market

The Pharmaceutical Glycerine Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Glycerine Market, highlighting leading vendors and their innovative profiles. These include Archer Daniels Midland Company, Emery Oleochemicals Group, Fisher Scientific Co. L.L.C., GJ Chemical, Godrej Group, Merck KGaA, Münzer Bioindustrie GmbH, Oleon NV, Pon Pure Chemicals Group, Procter and Gamble Company, Reagents, Renewable Energy Group Inc., Sulzer Ltd, The Chemical Company, and Viterra Magdeburg GmbH.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Glycerine Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Utility
    • Care Products
    • Excipient
  • Source
    • Animal
    • Plant
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing usage as excipients in pharmaceutical preparations
5.1.1.2. Rising adoption of natural ingredients
5.1.1.3. Increasing application in the treatment of eye pressure conditions
5.1.2. Restraints
5.1.2.1. Adverse effects of pharmaceutical glycerine
5.1.3. Opportunities
5.1.3.1. Rising R&D activities to develop pharmaceutical glycerine
5.1.3.2. Improvements in supply chain and distribution network
5.1.4. Challenges
5.1.4.1. Availability of low cost substitutes
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Pharmaceutical Glycerine Market, by Utility
6.1. Introduction
6.2. Care Products
6.3. Excipient
7. Pharmaceutical Glycerine Market, by Source
7.1. Introduction
7.2. Animal
7.3. Plant
8. Americas Pharmaceutical Glycerine Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Pharmaceutical Glycerine Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Pharmaceutical Glycerine Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PHARMACEUTICAL GLYCERINE MARKET RESEARCH PROCESS
FIGURE 2. PHARMACEUTICAL GLYCERINE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PHARMACEUTICAL GLYCERINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PHARMACEUTICAL GLYCERINE MARKET DYNAMICS
TABLE 7. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY CARE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY EXCIPIENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY PLANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 20. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 21. CANADA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 22. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 23. MEXICO PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 32. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 33. CHINA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 35. INDIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 39. JAPAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 50. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 51. THAILAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 59. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 60. EGYPT PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 61. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 62. FINLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 63. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 64. FRANCE PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 65. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 66. GERMANY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 69. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 70. ITALY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 75. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 76. NORWAY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 77. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 78. POLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 79. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 80. QATAR PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 87. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 88. SPAIN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 93. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 94. TURKEY PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY UTILITY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM PHARMACEUTICAL GLYCERINE MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 99. PHARMACEUTICAL GLYCERINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 100. PHARMACEUTICAL GLYCERINE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Pharmaceutical Glycerine Market, which are profiled in this report, include:
  • Archer Daniels Midland Company
  • Emery Oleochemicals Group
  • Fisher Scientific Co. L.L.C.
  • GJ Chemical
  • Godrej Group
  • Merck KGaA
  • Münzer Bioindustrie GmbH
  • Oleon NV
  • Pon Pure Chemicals Group
  • Procter and Gamble Company
  • Reagents
  • Renewable Energy Group Inc.
  • Sulzer Ltd
  • The Chemical Company
  • Viterra Magdeburg GmbH

Methodology

Loading
LOADING...

Table Information